FTO-Dependent N6-Methyladenosine Modifications Inhibit Ovarian Cancer Stem Cell Self-Renewal by Blocking cAMP Signaling

Published on Aug 15, 2020in Cancer Research9.727
· DOI :10.1158/0008-5472.CAN-19-4044
Hao Huang25
Estimated H-index: 25
(NU: Northwestern University),
Hao Huang31
Estimated H-index: 31
(NU: Northwestern University)
+ 8 AuthorsDaniela Matei59
Estimated H-index: 59
(NU: Northwestern University)
N6-Methyladenosine (m6A) is the most abundant modification of mammalian messenger RNAs (mRNA). RNA methylation fine tunes RNA stability and translation, altering cell fate. The fat mass- and obesity-associated protein (FTO) is an m6A demethylase with oncogenic properties in leukemia. Here we show that FTO expression is suppressed in ovarian tumors and cancer stem cells (CSC). FTO inhibited the self-renewal of ovarian CSC and suppressed tumorigenesis in vivo, both of which required FTO demethylase activity. Integrative RNA-sequencing and m6A mapping analysis revealed significant transcriptomic changes associated with FTO overexpression and m6A loss involving stem cell signaling, RNA transcription, and mRNA splicing pathways. By reducing m6A levels at the 3'UTR and the mRNA stability of two phosphodiesterase genes (PDE1C and PDE4B), FTO augmented second messenger 3', 5'-cyclic adenosine monophosphate (cAMP) signaling and suppressed stemness features of ovarian cancer cells. Our results reveal a previously unappreciated tumor suppressor function of FTO in ovarian CSC mediated through inhibition of cAMP signaling.
📖 Papers frequently viewed together
38 Citations
31 Citations
11 Authors (Guifang Jia, ..., Chuan He)
1,586 Citations
#1Takeshi Fukumoto (Wistar Institute)H-Index: 11
#1Takeshi Fukumoto (Wistar Institute)H-Index: 21
Last. Rugang Zhang (Wistar Institute)H-Index: 42
view all 12 authors...
Despite the high initial response rates to PARP inhibitors (PARPi) in BRCA-mutated epithelial ovarian cancers (EOC), PARPi resistance remains a major challenge. Chemical modifications of RNAs have emerged as a new layer of epigenetic gene regulation. N6-methyladenosine (m6A) is the most abundant chemical modification of messenger RNA (mRNA), yet the role of m6A modification in PARPi resistance has not previously been explored. Here we show that m6A modification of FZD10 mRNA contributes to PARPi...
52 CitationsSource
#1Ilana Chefetz (UM: University of Michigan)H-Index: 17
#1Ilana Chefetz (UM: University of Michigan)H-Index: 1
Last. Ronald J. BuckanovichH-Index: 42
view all 26 authors...
Summary Ovarian cancer is typified by the development of chemotherapy resistance. Chemotherapy resistance is associated with high aldehyde dehydrogenase (ALDH) enzymatic activity, increased cancer “stemness,” and expression of the stem cell marker CD133. As such, ALDH activity has been proposed as a therapeutic target. Although it remains controversial which of the 19 ALDH family members drive chemotherapy resistance, ALDH1A family members have been primarily linked with chemotherapy resistant a...
39 CitationsSource
#1Jun Liu (U of C: University of Chicago)H-Index: 6
#2Mark A. Eckert (U of C: University of Chicago)H-Index: 59
Last. Chuan He (U of C: University of Chicago)H-Index: 134
view all 20 authors...
N6-methyladenosine (m6A) messenger RNA methylation is a gene regulatory mechanism affecting cell differentiation and proliferation in development and cancer. To study the roles of m6A mRNA methylation in cell proliferation and tumorigenicity, we investigated human endometrial cancer in which a hotspot R298P mutation is present in a key component of the methyltransferase complex (METTL14). We found that about 70% of endometrial tumours exhibit reductions in m6A methylation that are probably due t...
246 CitationsSource
#1Liujia He (ZJU: Zhejiang University)H-Index: 6
#2Jiangfeng Li (ZJU: Zhejiang University)H-Index: 12
Last. Liping Xie (ZJU: Zhejiang University)H-Index: 35
view all 8 authors...
: As the most abundant and reversible RNA modification in eukaryotic cells, m6 A triggers a new layer of epi-transcription. M6 A modification occurs through a methylation process modified by "writers" complexes, reversed by "erasers", and exerts its role depending on various "readers". Emerging evidence shows that there is a strong association between m6 A and human diseases, especially cancers. Herein, we review bi-aspects of m6 A in regulating cancers mediated by the m6 A-associated proteins, ...
26 CitationsSource
#1Qi Jason Yao (CAS: Chinese Academy of Sciences)H-Index: 1
#2Lina Sang (Sichuan University)H-Index: 1
Last. Bo Zhou (CAS: Chinese Academy of Sciences)H-Index: 27
view all 7 authors...
38 CitationsSource
#1Salvatore Condello (NU: Northwestern University)H-Index: 18
#2Livia Elena Sima (NU: Northwestern University)H-Index: 17
Last. Daniela Matei (NU: Northwestern University)H-Index: 59
view all 7 authors...
Cancer progression and recurrence are linked to a rare population of cancer stem cells (CSC). Here we hypothesized that interactions with the extracellular matrix drive CSC proliferation and tumor-initiating capacity and investigated the functions of scaffold protein tissue transglutaminase (TG2) in ovarian CSC. Complexes formed by TG2, fibronectin (FN), and integrin β1 were enriched in ovarian CSC and detectable in tumors. A function-inhibiting antibody against the TG2 FN-binding domain suppres...
28 CitationsSource
#1Xiaolan Deng (PRC: China Medical University (PRC))H-Index: 12
#2Rui Su (University of Cincinnati Academic Health Center)H-Index: 24
Last. Jianjun Chen (University of Cincinnati Academic Health Center)H-Index: 62
view all 6 authors...
N6-methyladenosine (m6A), the most abundant internal modification in eukaryotic messenger RNAs (mRNAs), has been shown to play critical roles in various normal bioprocesses such as tissue development, stem cell self-renewal and differentiation, heat shock or DNA damage response, and maternal-to-zygotic transition. The m6A modification is deposited by the m6A methyltransferase complex (MTC; i.e., writer) composed of METTL3, METTL14 and WTAP, and probably also VIRMA and RBM15, and can be removed b...
191 CitationsSource
#1Huilin Huang (University of Cincinnati Academic Health Center)H-Index: 19
#2Hengyou Weng (University of Cincinnati Academic Health Center)H-Index: 3
Last. Jianjun Chen (University of Cincinnati Academic Health Center)H-Index: 62
view all 30 authors...
N6-methyladenosine (m6A) is the most prevalent modification in eukaryotic messenger RNAs (mRNAs) and is interpreted by its readers, such as YTH domain-containing proteins, to regulate mRNA fate. Here, we report the insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs; including IGF2BP1/2/3) as a distinct family of m6A readers that target thousands of mRNA transcripts through recognizing the consensus GG(m6A)C sequence. In contrast to the mRNA-decay-promoting function of YTH domain-contain...
541 CitationsSource
#1Saskia Klutzny (Technical University of Berlin)H-Index: 2
#2Anna Anurin (Bayer)H-Index: 1
Last. Patrick Steigemann (Bayer)H-Index: 3
view all 8 authors...
Cancer stem cells (CSCs) are involved in metastasis and resistance development, thus affecting anticancer therapy efficacy. The underlying pathways required for CSC maintenance and survival are not fully understood and only a limited number of treatment strategies to specifically target CSCs have been identified. To identify novel CSC targeting compounds, we here set-up an aldehyde dehydrogenase (ALDH)-based phenotypic screening system that allows for an automated and standardized identification...
13 CitationsSource
#1Rui Su (UC: University of Cincinnati)H-Index: 24
#2Lei Dong (UC: University of Cincinnati)H-Index: 23
Last. Jianjun Chen (UC: University of Cincinnati)H-Index: 62
view all 32 authors...
Summary R-2-hydroxyglutarate (R-2HG), produced at high levels by mutant isocitrate dehydrogenase 1/2 (IDH1/2) enzymes, was reported as an oncometabolite. We show here that R-2HG also exerts a broad anti-leukemic activity in vitro and in vivo by inhibiting leukemia cell proliferation/viability and by promoting cell-cycle arrest and apoptosis. Mechanistically, R-2HG inhibits fat mass and obesity-associated protein (FTO) activity, thereby increasing global N 6 -methyladenosine (m 6 A) RNA modificat...
344 CitationsSource
Cited By20
#1Lin-Lin Zhou (CAS: Chinese Academy of Sciences)
#2Hongjiao Xu (CAS: Chinese Academy of Sciences)H-Index: 3
Last. Cai-Guang Yang (CAS: Chinese Academy of Sciences)H-Index: 24
view all 4 authors...
N null null null null null 6 null -Methyladenosine (m6A) is the most prevalent internal modification on mRNA and represents a new layer of gene expression in eukaryotes. The field of m6A-encoded epitranscriptomics was rejuvenated with the discovery of fat mass and obesity-associated protein (FTO) as the first m6A demethylase responsible for RNA modification in cells. Increasing evidence has revealed that FTO is significantly involved in physiological processes, and its dysregulation is implicate...
#1Yin Li (Fudan University)H-Index: 4
#2Jie Gu (Fudan University)H-Index: 17
Last. Chunlai Lu (Fudan University)H-Index: 16
view all 7 authors...
N6-methyladenosine (m6A) modification can regulate a variety of biological processes. However, the implications of m6A modification in lung adenocarcinoma (LUAD) remain largely unknown. Here, we systematically evaluated the m6A modification features in more than 2400 LUAD samples by analyzing the multi-omics features of 23 m6A regulators. We depicted the genetic variation features of m6A regulators, and found mutations of FTO and YTHDF3 were linked to worse overall survival. Many m6A regulators ...
8 CitationsSource
#1Jianfeng Zheng (Nanjing Medical University)H-Index: 2
#2Jialu GuoH-Index: 1
Last. Jinyi Tong (Nanjing Medical University)H-Index: 1
view all 5 authors...
BACKGROUND Both N6-methyladenosine (m6A) modification and lncRNAs play an important role in the carcinogenesis and cancer inhibition of ovarian cancer (OC). However, lncRNAs involved in m6A regulation (LI-m6As) have never been reported in OC. Herein, we aimed to identify and validate a signature based on LI-m6A for OC. METHODS RNA sequencing profiles with corresponding clinical information associated with OC and 23 m6A regulators were extracted from TCGA. The Pearson correlation coefficient (PCC...
#1Dan-Yun Ruan (SYSU: Sun Yat-sen University)H-Index: 11
#1Dan-Yun Ruan (SYSU: Sun Yat-sen University)H-Index: 1
Last. De-Shen Wang (SYSU: Sun Yat-sen University)H-Index: 9
view all 17 authors...
Fat mass and obesity-associated protein (FTO), an N6-methyladenosine (m6A) demethylase, participates in tumor progression and metastasis in many malignancies, but its role in colorectal cancer (CRC) is still unclear. Here, we found that FTO protein levels, but not RNA levels, were downregulated in CRC tissues. Reduced FTO protein expression was correlated with a high recurrence rate and poor prognosis in resectable CRC patients. Moreover, we demonstrated that hypoxia restrained FTO protein expre...
#1Dean Paes (University of Würzburg)
#1Dean Paes (University of Würzburg)
Last. Jos Prickaerts (University of Würzburg)
view all 6 authors...
The phosphodiesterase 4 (PDE4) enzyme family plays a pivotal role in regulating levels of the second messenger cAMP. Consequently, PDE4 inhibitors have been investigated as a therapeutic strategy to enhance cAMP signaling in a broad range of diseases, including several types of cancers, as well as in various neurologic, dermatological, and inflammatory diseases. Despite their widespread therapeutic potential, the progression of PDE4 inhibitors into the clinic has been hampered because of their r...
#1Duo Wang (PRC: China Medical University (PRC))H-Index: 1
#2Xiujuan QuH-Index: 29
Last. Jiawen XiaoH-Index: 3
view all 12 authors...
Abnormal RNA m6A methylation is known to lead to the occurrence and progression of multiple cancers including gastric cancer (GC). However, the integrative effects of all m6A methylation regulators on GC prognosis are unclear. Our research aimed to globally analyze the prognosis values of all 33 m6A RNA methylation regulators in GC by univariate and multivariate Cox regression analyses. Among all 33 m6A RNA methylation regulators, fat mass and obesity-associated protein (FTO), an m6A demethylase...
#1Rui-Xi Hua (Guangzhou Medical University)H-Index: 18
#1Rui-Xi Hua (Guangzhou Medical University)H-Index: 1
Last. Jing He (Guangzhou Medical University)H-Index: 29
view all 11 authors...
BACKGROUND Wilms tumor is the most frequently occurring renal malignancy in pediatrics. The FTO gene exhibits a featured genetic contribution to cancer development. Nonetheless, its single nucleotide polymorphism (SNP) contribution to Wilms tumor is still unknown. METHODS Here, 402 Wilms tumor patients and 1198 healthy controls were successfully genotyped for FTO gene SNPs (rs1477196 G>A, rs9939609 T>A, rs7206790 C>G, and rs8047395 A>G) using TaqMan SNP genotyping assays. Odds ratios (ORs) and 9...
#1Kai Zhu (Southern Medical University)H-Index: 1
#2Ying Li (Changzhi Medical College)H-Index: 1
Last. Yikai Xu (Southern Medical University)H-Index: 1
view all 3 authors...
Abstract Aims N6-Methyladenosine (m6A) is the most frequent posttranscriptional modification and plays important roles in tumorigenesis and metastasis. The roles of fat mass and obesity-associated (FTO) in metabolic diseases have been widely explored. However, the molecular mechanisms and physiological functions of FTO in prostate cancer remain largely unknown. This study aimed to explore the exact functions of FTO in the progression of prostate cancer metastasis. Main methods Dot blot and m6A R...
1 CitationsSource
Last. Yuan Liu (FIU: Florida International University)H-Index: 14
view all 3 authors...
N6-methyladenosine (m6A) modification in mRNAs and non-coding RNAs is a newly identified epitranscriptomic mark. It provides a fine-tuning of gene expression to serve as a cellular response to endogenous and exogenous stimuli. m6A is involved in regulating genes in multiple cellular pathways and functions, including circadian rhythm, cell renewal, differentiation, neurogenesis, immunity, among others. Disruption of m6A regulation is associated with cancer, obesity, and immune diseases. Recent st...
#1Sebastien Relier (French Institute of Health and Medical Research)H-Index: 1
#2Julie Ripoll (CNRS: Centre national de la recherche scientifique)H-Index: 1
Last. Alexandre David (French Institute of Health and Medical Research)H-Index: 41
view all 22 authors...
Cancer stem cells (CSCs) are a small but critical cell population for cancer biology since they display inherent resistance to standard therapies and give rise to metastases. Despite accruing evidence establishing a link between deregulation of epitranscriptome-related players and tumorigenic process, the role of messenger RNA (mRNA) modifications in the regulation of CSC properties remains poorly understood. Here, we show that the cytoplasmic pool of fat mass and obesity-associated protein (FTO...
1 CitationsSource